Latest Safety News

HITIQ Limited has launched its PROTEQT™ concussion management system in North America, securing exclusive Canadian distribution rights and initiating a dual-channel market strategy targeting hockey’s vast ecosystem.

Cyprium Metals has secured board approval to restart copper cathode production at its Nifty Copper Complex, targeting first output by mid-2026. The plan leverages existing heap leach resources and refurbishes key processing infrastructure to generate near-term cash flow.

HeraMED has achieved a significant regulatory milestone with the Therapeutic Goods Administration upgrading its HeraBEAT fetal heart rate monitor to Class IIb, making it the only remote home-use device approved in Australia. This positions the company for a potentially lucrative expansion in the Australian maternity care market.

AXP Energy reports sustained strong flowback at its Charlie #1 well in Oklahoma, moving swiftly to install infrastructure for natural gas sales and early revenue generation.

Qube Holdings reported a robust FY25 with significant revenue and earnings growth, strategic acquisitions, and a refreshed board leadership. Despite operational challenges, the company raised its dividend and confirmed solid FY26 earnings guidance.

NexGen Energy has entered the final phase of federal regulatory approval for its flagship Rook I uranium project, marking a pivotal step toward construction and production. This follows over a decade of environmental assessments and provincial approvals.

Worley Limited reported solid financial results for FY2025, highlighted by disciplined capital management including a $269 million share buy-back and a strong focus on sustainability. The company outlined strategic priorities and anticipates moderate growth in FY2026 with a new growth strategy to be revealed next year.

Tasmea Limited reported robust FY25 financial results with a 74% jump in net profit after tax, driven by organic growth and strategic acquisitions. The company reaffirmed its FY26 guidance, supported by a $43 million institutional placement to fuel further expansion.

Bio-Gene Technology reports significant progress in developing its bio-insecticides Flavocide and Qcide, including new efficacy data and organic certification, positioning the company for growth amid rising global demand for safer pest control.

Experience Co Limited reported a strong FY25 with record revenue and earnings growth, driven by its Skydiving and Adventure Experiences segments. The company is advancing organic growth and acquisitions while maintaining disciplined capital management heading into FY26.

LGI Limited reported robust FY25 results with a 14% rise in EBITDA and secured six new contracts, positioning the company for a 25-30% EBITDA increase in FY26. Key project completions and expansions underpin this momentum.

LGI Limited reported robust FY25 results, expanding electricity capacity by 44% and increasing EBITDA by 14%, driven by new landfill gas contracts and battery storage projects. The company is well positioned to capitalize on Australia’s renewable energy transition and evolving carbon credit market.